home

WuXi AppTec Acquires Crelux

EVENTSprnewswire2016-04-18 11:04 Read   65

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, today announced that it has acquired Crelux GmbH, a leading structure based drug discovery provider based in Munich, Germany.

Merck drops once-weekly diabetes drug in US and EU

EVENTSpmlive2016-04-18 10:41 Read   73

Merck & Co will no longer file for approval of once-weekly diabetes drug omarigliptin in the US or Europe, even though it is already on the market in Japan.

Stallergenes Greer PLC: Daniel Smith Appointed Global Head of Information Technology

EVENTSbusinesswire2016-04-18 09:18 Read   78

Stallergenes Greer plc, a biopharmaceutical company specializing in treatments for respiratory allergies, today announced the appointment of Daniel Smith as Global Head of Information Technology.

Macrocure Announces Receipt of NASDAQ Minimum Bid Price Notification

EVENTSYAHOO2016-04-18 09:07 Read   53

Macrocure Ltd. (MCUR), a clinical-stage biotechnology company, today announced that on April 7, 2016, Macrocure received a notice from NASDAQ regarding its non-compliance with the $1 per share minimum bid price requirement stated in NASDAQ Listing Rule 5450(a)(1).

China's tougher vaccine rules 'welcome', complex to implement: WHO

EVENTSreuters2016-04-15 17:38 Read   66

China's proposals to impose tougher rules over its vaccine market will help stamp out illegal behavior and strengthen oversight, but will be "complex" to implement, the World Health Organization (WHO) said in a statement on Friday.

With $40M Led by GV, Quartet Expands Tech for Mental Health Care

EVENTSxconomy2016-04-15 17:12 Read   69

Quartet Health, the data-focused New York company that is trying to connect what it calls behavioral and physical healthcare, has received a $40 million Series B round led by GV, the venture capital arm of Google’s parent company, Alphabet.

U.S. Drug Spending Climbs

EVENTSwsj2016-04-15 14:09 Read   97

Growth rate slows but remains at high level, fueled by pricey new medications

Exclusive: Lonza in bid to acquire Catalent - sources

EVENTSreuters2016-04-15 14:02 Read   58

Swiss specialty chemicals and life sciences company Lonza Group AG (LONN.S) has offered to acquire U.S. drug delivery technology company Catalent Inc (CTLT.N), three people familiar with the matter said this week.

AZ, BMS get a breather as India yanks CL appeals

EVENTSReuters2016-04-15 13:37 Read   303

Compulsory license applications in India for Sprycel (dasatinib) from Bristol-Myers Squibb ($BMS) and Onglyza (saxagliptin) from AstraZeneca ($AZN) have been quietly withdrawn as firms in the space suggest at least a higher bar has been set.

China genomics giant BGI targets A-share IPO

EVENTSfinanceasia2016-04-15 13:27 Read   189

BGI, one of the world’s largest genome sequencing companies, is targeting an A-share Chinese listing to help raise capital for development and acquisitions, some of them overseas.

Roche clears drug that caused vision loss in India

EVENTSswissinfo2016-04-15 11:21 Read   89

An internal enquiry by the Swiss pharma giant Roche has revealed no quality problems with its anti-cancer drug Avastin, which resulted in vision loss in 15 patients in India. The drug was being used to treat eye problems without regulatory approval. 

Billion-dollar T-cell biotech Bavarian Nordic abandons $86 million US listing

EVENTSrenaissancecapital2016-04-15 10:15 Read   89

Bavarian Nordic, which is developing vaccines that stimulate a T-cell response to fight infectious diseases and cancers, withdrew its plans for an initial public offering on Wednesday, citing market conditions. It originally filed in January 2016 with a proposed deal size of $86 million.